Renaissance Technologies’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-445,019
Closed -$48M 3683
2023
Q2
$48M Sell
445,019
-64,572
-13% -$7.26M 0.07% 328
2023
Q1
$63.5M Buy
509,591
+178,107
+54% +$24.5M 0.08% 284
2022
Q4
$49.8M Buy
+331,484
New +$51M 0.07% 339
2022
Q3
Sell
-238,619
Closed -$35.6M 4038
2022
Q2
$35.6M Sell
238,619
-11,800
-5% -$1.8M 0.04% 471
2022
Q1
$42.7M Buy
+250,419
New +$42.1M 0.05% 395
2021
Q3
Sell
-328,614
Closed -$73.6M 3484
2021
Q2
$73.6M Buy
+328,614
New +$62M 0.09% 227

Other funds holding BNTX

Renaissance Technologies's BNTX Position: Q3 2023 in Review

Renaissance Technologies sold out of BioNTech (BNTX) in Q3 2023, closing a stake of 445,019 shares — an estimated $48M sold.

Renaissance Technologies first reported a position in BNTX in Q2 2021 and held it in 6 quarters. The position peaked at $73.6M in Q2 2021. 252 funds tracked by Wall St. Rank hold BNTX as of Q3 2023.

  • Renaissance Technologies reported no remaining BioNTech position as of Q3 2023 after selling out during the quarter.
  • Renaissance Technologies sold 445,019 BioNTech shares in Q3 2023, an estimated $48M.
  • Renaissance Technologies first reported a position in BioNTech in Q2 2021 and held it in 6 quarters.
  • Renaissance Technologies's BioNTech position peaked at $73.6M in Q2 2021.
  • 252 funds tracked by Wall St. Rank held BioNTech as of Q3 2023.

Based on Renaissance Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.